These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23122952)

  • 1. Cell-derived microparticles and vascular pregnancy complications: a systematic and comprehensive review.
    Alijotas-Reig J; Palacio-Garcia C; Llurba E; Vilardell-Tarres M
    Fertil Steril; 2013 Feb; 99(2):441-9. PubMed ID: 23122952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cell-derived microparticles in women with pregnancy loss.
    Alijotas-Reig J; Palacio-Garcia C; Farran-Codina I; Zarzoso C; Cabero-Roura L; Vilardell-Tarres M
    Am J Reprod Immunol; 2011 Sep; 66(3):199-208. PubMed ID: 21276118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher levels of procoagulant microparticles in women with recurrent miscarriage are not associated with antiphospholipid antibodies.
    Martínez-Zamora MA; Tàssies D; Creus M; Reverter JC; Puerto B; Monteagudo J; Carmona F; Balasch J
    Hum Reprod; 2016 Jan; 31(1):46-52. PubMed ID: 26534898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cell-derived microparticles in severe preeclampsia and in fetal growth restriction.
    Alijotas-Reig J; Palacio-Garcia C; Farran-Codina I; Ruiz-Romance M; Llurba E; Vilardell-Tarres M
    Am J Reprod Immunol; 2012 Feb; 67(2):140-51. PubMed ID: 21992597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microparticles, lupus anticoagulant and recurrent miscarriages.
    Alijotas-Reig J; Palacio-Garcia C; Vilardell-Tarres M
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):22-6. PubMed ID: 19410360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of microparticles in recurrent miscarriages and other adverse pregnancies: a review.
    Shetty S; Patil R; Ghosh K
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):123-9. PubMed ID: 23490540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy.
    Yan J; Sripada S; Saravelos SH; Chen ZJ; Egner W; Li TC
    Fertil Steril; 2012 Aug; 98(2):378-82. PubMed ID: 22624672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia.
    Campello E; Spiezia L; Radu CM; Dhima S; Visentin S; Valle FD; Tormene D; Woodhams B; Cosmi E; Simioni P
    Thromb Res; 2015 Aug; 136(2):427-31. PubMed ID: 26037284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage.
    van den Boogaard E; Cohn DM; Korevaar JC; Dawood F; Vissenberg R; Middeldorp S; Goddijn M; Farquharson RG
    Fertil Steril; 2013 Jan; 99(1):188-192. PubMed ID: 23043688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial and platelet microparticles in patients with antiphospholipid antibodies.
    Breen KA; Sanchez K; Kirkman N; Seed PT; Parmar K; Moore GW; Hunt BJ
    Thromb Res; 2015 Feb; 135(2):368-74. PubMed ID: 25496997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased endometrial vascularity in patients with antiphospholipid antibodies-associated recurrent miscarriage during midluteal phase.
    Chen L; Quan S; Ou XH; Kong L
    Fertil Steril; 2012 Dec; 98(6):1495-502.e1. PubMed ID: 22959454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-beta(2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss.
    Alijotas-Reig J; Ferrer-Oliveras R; Rodrigo-Anoro MJ; Farran-Codina I; Cabero-Roura L; Vilardell-Tarres M
    Fertil Steril; 2010 May; 93(7):2330-6. PubMed ID: 19296946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: a prospective clinical study.
    Zolghadri J; Tavana Z; Kazerooni T; Soveid M; Taghieh M
    Fertil Steril; 2008 Sep; 90(3):727-30. PubMed ID: 18001723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study.
    Field K; Murphy DJ
    Hum Reprod; 2015 May; 30(5):1239-45. PubMed ID: 25759495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
    Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
    Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prior birth and miscarriage frequency on the prevalence of acquired and congenital uterine anomalies in women with recurrent miscarriage: a cross-sectional study.
    Jaslow CR; Kutteh WH
    Fertil Steril; 2013 Jun; 99(7):1916-22.e1. PubMed ID: 23472945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic pregnancy in women with recurrent miscarriage.
    Ticconi C; Capogna MV; Martelli F; Borelli B; Bruno V; Ergasti R; Sorge R; Piccione E; Pietropolli A
    J Obstet Gynaecol Res; 2018 May; 44(5):852-860. PubMed ID: 29442402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency of antiphospholipid antibodies and antiphospholipid syndrome in women with recurrent miscarriages].
    Rajewski M; Skrzypczak J
    Ginekol Pol; 2011 Jan; 82(1):32-8. PubMed ID: 21473054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal outcomes of women with a prior history of unexplained recurrent miscarriage.
    Dempsey MA; Flood K; Burke N; Fletcher P; Kirkham C; Geary MP; Malone FD
    J Matern Fetal Neonatal Med; 2015 Mar; 28(5):522-5. PubMed ID: 24824106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating cell-derived microparticle count is associated with recurrent implantation failure after IVF and embryo transfer.
    Martínez-Zamora MA; Tàssies D; Reverter JC; Creus M; Casals G; Cívico S; Carmona F; Balasch J
    Reprod Biomed Online; 2016 Aug; 33(2):168-73. PubMed ID: 27236712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.